Cognetivity: Echelon Raises Price Target To $1.50 After Biogen Approval
Monday was a very big day for companies who are in the business to help patients who suffer from Alzheimer’s,
Read more
Cognetivity Neurosciences
Cognetivity Neurosciences Files Patent For System Capable Of Early Detection Of Alzheimer’s Disease
Cognetivity Neurosciences (CSE: CGN) this morning announced that it has filed for a key new patent. The filing relates to
Read more
Cognetivity: Developing Tech For Early Detection Of Alzheimer’s – The Daily Dive feat Sina Habibi
For the final episode of The Deep Dive this week, we sit down with Sina Habibi, CEO of Cognetivity Neurosciences
Read more
Cognetivity Neurosciences: Echelon Initiates Coverage With $0.85 Price Target
On Friday, Echelon Capital Markets initiated coverage on Cognetivity Neurosciences (CSE: CGN) with a speculative buy rating and C$0.85 12-month
Read more
Cognetivity Neurosciences Sees Former UK Health Minister Appointed To Advisory Board
Cognetivity Neurosciences (CSE: CGN) this morning announced that it has added a former UK Health Minister to its advisory board.
Read more
Cognetivity Neurosciences To Deploy Wellness App With Dutch Telehealth Firm
Cognetivity Neurosciences (CSE: CGN) has reached the commercialization stage for one of its products. The company this morning announced that
Read more
Early Detection For Alzheimer’s Via AI Driven Cognitive Testing – The Daily Dive feat Thomas Sawyer
Joining us at the midpoint of the week on the Daily Dive, is that of Dr Thomas Sawyer, COO of
Read more
Cognitivity Neuroscience Sees UK Cognitive Study Advance To Remote Assessment
Cognetivity Neurosciences (CSE: CGN) this morning announced the expansion of an ongoing study in the UK related to its cognitive
Read more
Cognetivity Neurosciences Selected For Accelerator Program To Fast Track US Commercialization
Cognetivity Neurosciences (CSE: CGN) has been selected as one of just seven members of the Texas Medical Center Innovation Accelerator
Read more